Literature DB >> 330755

Expression of protein HC on the plasma membrane of different human cell types.

E Pearlstein, I Turesson, L Tejler, A O Grubb.   

Abstract

The surface expression of a recently described plasma glycoprotein called human complex-forming glycoprotein, hetergeneous in charge (protein HC) on a number of different human cell types was investigated. By means of direct and indirect immunofluorescence, protein HC was shown to be associated with the surface of virtually all cells of the investigated normal cell types including erythrocytes, peripheral blood B and T lymphocytes, and the human fibroblast lines HE 81, HE 31, and WI 38. When transformed and malignant cell populations were studied, it was found that some populations (e.g., the T cell line Molt-4) carried protein HC on the surfaces of very few cells, whereas other cell populations (e.g., chronic lymphocytic leukemia lymphocytes) carried the protein on most cells. Malignant cell populations with intermediary percentages of protein HC-positive cells were also found. Protein HC on the cell surface of normal peripheral blood lymphocytes could be redistributed by incubation of the cells with anti-protein HC-antiserum at 37 degrees C, and this reaction could be inhibited by sodium azide.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 330755

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  3 in total

1.  Localization of alpha 1-microglobulin (HC protein) in normal human tissues: an immunohistochemical study using monoclonal antibodies.

Authors:  P Bouic; C Vincent; J P Revillard
Journal:  Histochem J       Date:  1984-12

2.  Synthesis and secretion of alpha 1-microglobulin by human lymphocytes.

Authors:  Y Itoh; K Kin; T Kasahara; I Sakurabayashi; T Kawai; K Shiori-Nakano; K Takagi
Journal:  Clin Exp Immunol       Date:  1979-07       Impact factor: 4.330

3.  Tissue distribution of human alpha1-microglobulin.

Authors:  K Takagi; K Kin; Y Itoh; T Kawai; T Kasahara; T Shimoda; T Shikata
Journal:  J Clin Invest       Date:  1979-02       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.